Journal of Cystic Fibrosis 2024
6 papers
The 2024 volume of the *Journal of Cystic Fibrosis* focuses on the intersection of genetic modifiers and clinical management strategies. Research themes include the use of aggregated genetic modifiers to predict lung function in pediatric patients and the influence of genetic factors on Vitamin D status and supplement response. Technological developments in gene therapy are also featured, specifically regarding the integration of transgenes through the Find and cut-and-transfer (FiCAT) method.
Clinical research from this year examines the real-world effectiveness of *Pseudomonas aeruginosa* eradication protocols and shifts in inhaled antibiotic prescription patterns in the United States. Other studies investigate how pharmacological improvements in CFTR function restore airway epithelial homeostasis and host defense. Notable contributors to these findings include HuiChuan J. Lai, Philip M. Farrell, and Qiongshi Lu. These papers provide data on both the molecular mechanisms of cystic fibrosis and the evolving landscape of therapeutic interventions.
Top Authors
| Author | Papers |
|---|---|
| Qiongshi Lu | 2 |
| Irina Lehmann | 1 |
| Roland Eils | 1 |